WallStSmart
CYTK

Cytokinetics Inc

NASDAQ: CYTK · HEALTHCARE · BIOTECHNOLOGY

$63.97
+7.37% today

Updated 2026-04-30

Market cap
$7.54B
P/E ratio
P/S ratio
85.64x
EPS (TTM)
$-6.54
Dividend yield
52W range
$29 – $71
Volume
1.9M

Cytokinetics Inc (CYTK) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-47.17M$-3.00M$-61.33M$8.42M$-44.83M$-45.59M$-33.44M$-7.72M$-44.84M$4.88M$36.98M$-101.76M$-101.22M$-90.91M$8.94M$-142.52M$-299.52M$-414.33M$-395.89M$-510.01M
Capital expenditures$5.37M$2.56M$658000.00$550000.00$493000.00$443000.00$125000.00$542000.00$1.10M$562000.00$1.60M$2.88M$889000.00$2.62M$11.05M$48.87M$11.34M$1.42M$3.91M$24.81M
Depreciation
Stock-based comp$4.64M$4.64M$5.61M$4.91M$4.02M$3.07M$3.78M$3.60M$3.33M$4.57M$7.15M$9.03M$9.76M$10.76M$17.62M$26.83M$47.85M$72.06M$97.84M$112.29M
Free cash flow$-52.54M$-5.57M$-61.99M$7.87M$-45.32M$-46.04M$-33.56M$-8.26M$-45.95M$4.32M$35.39M$-104.64M$-102.10M$-93.53M$-2.11M$-191.39M$-310.85M$-415.75M$-399.80M$-534.82M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$18.46M
Share repurchases
Debt repayment
Net change in cash$1.32M$-3.93M$5.25M$57000.00$44.86M$1.80M$58.33M$-82.95M$-5.82M$46.55M$29.68M$-45.48M